ATNM News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2013-03-11 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K | Actinium Pharmaceuticals, Inc. filed Form 8-K covering items 1.01,2.01,3.02,9.01. |
| 2013-03-01 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K | Actinium Pharmaceuticals, Inc. filed Form 8-K covering items 5.02. |
| 2013-02-28 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K | Actinium Pharmaceuticals, Inc. filed Form 8-K covering items 5.02. |
| 2013-01-28 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K/A | Actinium Pharmaceuticals, Inc. filed Form 8-K/A covering items 1.01,2.01,3.02,4.01,5.01,5.02,5.05,5.06,9.01. |
| 2013-01-28 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K | Actinium Pharmaceuticals, Inc. filed Form 8-K covering items 8.01. |
| 2013-01-04 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K/A | Actinium Pharmaceuticals, Inc. filed Form 8-K/A covering items 1.01,2.01,3.02,4.01,5.01,5.02,5.05,5.06,9.01. |
| 2013-01-02 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K | Actinium Pharmaceuticals, Inc. filed Form 8-K covering items 1.01,2.01,3.02,4.01,5.01,5.02,5.05,5.06,9.01. |
| 2012-12-17 | Current report | SEC filing | Actinium Pharmaceuticals, Inc. filed Form 8-K | Actinium Pharmaceuticals, Inc. filed Form 8-K covering items 8.01,9.01. |